A Fireside Chat with Our Investors: Why BenchSci is the Horse They’re Backing
Dennis Kavelman, Partner at Inovia Capital, and Matt Brennan, Partner at TCV, shared with us why they chose to lead BenchSci’s $63M Series C funding.
Dennis Kavelman, Partner at Inovia Capital, and Matt Brennan, Partner at TCV, shared with us why they chose to lead BenchSci’s $63M Series C funding.
At BenchSci, transparency is one of our core values. Our CEO, Liran Belenzon, explains why we decided to found our culture on trust, not fear.